Canton Strategic Holdings (CNTN) Assets Average (2022 - 2026)
Canton Strategic Holdings (CNTN) reported Assets Average of $551.9 million for Q1 2026, up 20405.63% on a YoY basis from N/an in Q1 2025, and up 109.51% quarter-over-quarter from $263.4 million in Q4 2025.
Canton Strategic Holdings (CNTN) Assets Average (2022 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Assets Average for 5 years, with the latest figure at $551.9 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 20405.63% year-over-year to $551.9 million; the trailing twelve-month figure through Mar 2026 stood at $551.9 million (up 20405.63% YoY), and the FY2025 full-year result was $261.4 million, up 3464.68% from the prior year.
- Assets Average for Q1 2026 stood at $551.9 million, up from $263.4 million in the prior quarter.
- The five-year high for Assets Average was $551.9 million in Q1 2026, with the low at $2.1 million in Q2 2025.
- Historically, Assets Average has averaged $53.5 million across 5 years, with a median of $6.8 million in 2024.
- Annual changes were most pronounced in 2025 — Assets Average plunged 75.55% — and 2026, when it surged 20405.63%.
- Canton Strategic Holdings' Assets Average stood at $7.4 million in 2022, then declined by 4.04% to $7.1 million in 2023, then sank by 36.42% to $4.5 million in 2024, then soared by 5771.54% to $263.4 million in 2025, then surged by 109.51% to $551.9 million in 2026.
- The last three Assets Average figures came in at $551.9 million (Q1 2026), $263.4 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | 551.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 551.90 Mn |
| Dec 31, 2025 | 263.42 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 4.49 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | 8.57 Mn |
| Mar 31, 2024 | 9.92 Mn |
| Dec 31, 2023 | 7.06 Mn |
| Sep 30, 2023 | 3.88 Mn |
| Jun 30, 2023 | 4.66 Mn |
| Mar 31, 2023 | 5.71 Mn |
| Dec 31, 2022 | 7.35 Mn |
| Sep 30, 2022 | 9.13 Mn |
| Jun 30, 2022 | 11.17 Mn |
| Mar 31, 2022 | 6.36 Mn |